An immunotherapy startup that pulled off a $133 million IPO last year is shuttering its Boston research operations and laying off about 40% of its workforce.
An immunotherapy startup that pulled off a $133 million IPO last year is shuttering its Boston research operations and laying off about 40% of its workforce.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.